NMRA

Neumora Therapeutics
$1.66
+$0.17 (+11.41%)Jul 27, 2026
0.8PoorMoatMint rating

MoatMint rates Neumora Therapeutics (NMRA) 0.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.7 out of 10.

Key metrics

The numbers that frame NMRA today
Market cap
$307.57M
P/E (TTM)
-1.4
EV / FCF
-1.1
ROIC
-430.6%
Div yield
0%
Debt / equity
0.8
52wk Low
$0.83
52wk High
$3.65

NMRA stock rating

How NMRA scores on quality, value, growth, momentum and financial health
0.8out of 10
Low overallNeutral business, expensive priceTop 92% of ~5,000 US stocks
QualityPoor1.7/10
GrowthNeutral5.2/10
MomentumFair2.2/10
ValuePoor0.4/10
Financial HealthPoor1.2/10

Growth

Revenue and earnings trend for NMRA
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NMRA
Is Neumora Therapeutics a good buy?
No. Neumora Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Neumora Therapeutics is selling at a very high price.
What is the market capitalization of NMRA?
Neumora Therapeutics's market capitalization is $307.57M.
What is the P/E ratio for NMRA stock?
Neumora Therapeutics's current P/E ratio is -1.4.
What is the 52-week high for NMRA stock?
The 52-week high for Neumora Therapeutics is $3.65. The current close of $1.66 is 54.5% below that high.
What is the 52-week low for NMRA stock?
The 52-week low for Neumora Therapeutics is $0.83. The current close of $1.66 is 100% above that low.
Does NMRA stock pay dividends?
Neumora Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NMRA?
Neumora Therapeutics's Debt / Equity ratio is 0.76.